Actively Recruiting
A Bioequivalence Study of Two Formulations of HRS-1893 Tablets in Healthy Participants
Led by Shandong Suncadia Medicine Co., Ltd. · Updated on 2026-04-17
36
Participants Needed
1
Research Sites
11 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will investigate the bioequivalence between two formulations of HRS-1893 tablets. Safety and tolerability will also be assessed.
CONDITIONS
Official Title
A Bioequivalence Study of Two Formulations of HRS-1893 Tablets in Healthy Participants
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 55 years, any gender
- Body mass index (BMI) between 19 and 28 kg/m²
- Body weight 50 to less than 90 kg for men, 45 to less than 90 kg for women
- No significant abnormalities in physical exams and lab tests, or only minor ones not affecting eligibility
- Normal 12-lead ECG without clinically significant abnormalities
- Understands study procedures, agrees to participate, and provides written informed consent
You will not qualify if you...
- Known hypersensitivity to the investigational drug or any ingredients
- History of fainting (syncope)
- Systolic blood pressure over 140 mmHg or under 90 mmHg, or diastolic blood pressure over 90 mmHg or under 60 mmHg
- History of stomach or intestinal surgery affecting drug absorption
- Positive test for hepatitis B, hepatitis C, syphilis, or HIV during screening
- Smoking more than 5 cigarettes daily in the 4 weeks before screening
- Drinking more than 15 grams of alcohol daily in the week before screening
- Inability or unwillingness to avoid smoking, alcohol, and caffeine during screening and study
- Special dietary needs or history of substance abuse
- Use of prescription, over-the-counter, or herbal medicines within 1 month before dosing or any drug within 5 half-lives before screening
- Any other medical or psychological condition that makes participation unsafe or affects study compliance
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Beijing Hospital
Beijing, Beijing Municipality, China, 100730
Actively Recruiting
Research Team
W
Wenzheng Xiong
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here